PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

Clinical trial NCT01066793 · COMPLETED

Trial details

NCT number: NCT01066793
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatitis C, Chronic

Start date: 2007-10-01
Primary completion: 2011-03-01
Enrollment: 2343

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.